Revenue fell 36% but gross margin flipped positive as equity collapsed 66%

Comparable note: FY21 was selected on an inferred basis rather than an exact same-period filing match.

What changed

Operating revenue fell 35.9% to NZ$0.4m from NZ$0.6m, yet the FY22 loss narrowed across every line: gross profit flipped to NZ$31.1k positive from a NZ$247.3k loss, PBT improved 20.2% to a NZ$0.7m loss, and NPAT attributable to equity holders narrowed 12.9% to NZ$0.4m. Operating cash outflow shrank to NZ$0.1m from NZ$0.5m, with closing cash up to NZ$14.5k. The balance sheet, however, contracted sharply: total assets fell 39.4% to NZ$1.9m and total equity collapsed 66.2% to NZ$0.6m, while gross borrowings were unchanged at NZ$53.4k. No dividend was declared.

What matters

• Margin reset is the cleaner read than revenue. Cost of sales fell to 92.5% of revenue from 138.2%, taking gross margin from -38.2% to +7.5%. That, more than scale, is what turned a deeper loss into a shallower one. Whether this is a pricing reset that holds, or simply the absence of the FY21 stock impairment, is not separately disclosed.
• Equity shrank by far more than the reported loss. Equity fell NZ$1.09m but NPAT attributable to parent was only NZ$0.40m. The release excerpts do not reconcile the residual c.NZ$0.7m drawdown, which sits alongside a PBT/NPAT gap of NZ$0.34m on nil tax — consistent with non-controlling interest absorbing part of the loss, but not transparently shown.
• Second-half shape was the stronger half. HY22 carried only 26.7% of full-year revenue and 62% of the full-year NPAT loss, implying an implied H2 revenue of NZ$0.3m and a smaller H2 loss of NZ$0.15m. Run-rate momentum is in the right direction even as the FY22 vs FY21 headline shows revenue down.

Expectations

No quantified guidance, forward-work book, or medium-term target was disclosed in the release excerpts, so there is no anchor to judge against. The implied second-half revenue (NZ$0.3m versus NZ$0.1m in HY22) and smaller H2 loss support a directional improvement story, but at this scale the result tells you almost nothing about a sustainable run rate. The release does not support any view on FY23 revenue level or path to break-even.

Quality of result

The earnings improvement is real but narrow. The gross margin flip and the NZ$0.36m improvement in operating cash outflow are durable in form — neither is obviously timing-driven — but both are measured against an unusually weak FY21 hit by COVID-related sales weakness and stock impairment. Free cash flow pre-lease was still negative at NZ$0.13m after NZ$4.4k of capex, so the business is not yet self-funding. Receivable days collapsed from 103 to 8 (a real cash benefit) but inventory days rose to 335 from 275, tying up working capital. With cash of only NZ$14.5k and equity down to NZ$0.55m, the result looks balance-sheet-thin rather than balance-sheet-assisted.

Unresolved

• What explains the c.NZ$0.7m gap between the equity decline and the reported loss? The excerpts do not show capital movements, OCI, or NCI splits.
• Is the gross margin shift a structural pricing/cost reset, or simply the non-repeat of an FY21 stock impairment embedded in cost of sales?
• With cash at NZ$14.5k against an annual operating outflow of NZ$0.13m, what is the funding plan? Borrowings were unchanged and no equity raise is referenced in the excerpts.
• Why did inventory days rise to 335 against falling revenue, and is further write-down risk present?

This briefing cannot assess the underlying viability of the business model, the funding pipeline beyond reporting date, or any segment/customer concentration, as none of that detail is in the supplied excerpts.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.